TSINGKE

Tsingke Biotech

@tsingke

Beijing
Biotechnology

Overview

About Tsingke Biotech

Tsingke Biotech is at the forefront of synthetic biology, dedicated to building a ‘world-class gene factory.

The company integrates advanced AI-driven molecular manufacturing technologies, mastering the core capabilities of gene reading, editing, and writing, and has established a fully independent R&D ecosystem that spans the entire chain from raw materials to sequencing.

Three Intelligent Manufacturing Platforms:

- AI-powered High-Throughput Oligonucleotide Screening Platform
- AI-powered High-Throughput Antibody Discovery Platform
- AI-powered High-Throughput Microbial Strain Engineering Platform

These platforms enable fully automated, scalable processes from gene design to functional molecule screening, delivering efficient and precise foundational support for biopharmaceuticals, biomanufacturing, agriculture, food, and environmental applications.

Headquartered in Beijing, Tsingke Biotech operates a 12,000+㎡ state-of-the-art R&D center and cleanroom facilities, holds over 300 independent intellectual property rights, and maintains medical device and quality management certifications.

Guided by the values of Quality, Innovation, Dedication, and Win-Win Collaboration, Tsingke Biotech applies intelligent, factory-oriented approaches to advance biotechnology and drive industry development.

Headquarters

Beijing

Website

-

Company Size

1,001-5,000 employees

Industry

Biotechnology

Company Type

Privately Held

Founded

2004

Specialties

Gene Synthesis, Oligo Synthesis, Synthetic Biology, Equipment Automation, Molecular Biology, DNA Synthesis, Biotechnology, Cell Therapy, Gene Therapy, Genetics, Molecular Genetics, Plant Genetics, Animal Genetics, and Cytogenetics

Posts